Viper Energy, Inc. last reported quarterly results on Nov 2, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $656.0 million (+66.9% year over year) and diluted EPS of $0.72. It usually reports 33–54 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 22, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Feb 23, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 33–54 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 2, 2026
33 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
656
+66.9%
|
140
+281.8%
|
0.72
+238.5%
|
|
Aug 3, 2026
34 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
658
|
142
|
0.73
|
|
May 4, 2026
34 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
496
|
97
|
0.53
|
|
Feb 23, 2026
54 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
422
|
-103
|
-0.61
|
|
Nov 3, 2025
34 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
393
|
-77
|
-0.52
|
Company profile
- Industry
- Crude Petroleum & Natural Gas (SIC 1311)
- Listed as
- VNOM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Midland, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 2074176
- Former names
- New Cobra Pubco, Inc. (until Jul 18, 2025)
Other Crude Petroleum & Natural Gas companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.